The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of disitamab vedotin (RC48) in combination with tislelizumab and bevacizumab in patients (Pts) with HER2 alterations locally advanced or metastatic NSCLC: Primary analysis results of RESOLUTION.
 
Jianing Chen
No Relationships to Disclose
 
Xinyu Zhang
No Relationships to Disclose
 
Li Liu
No Relationships to Disclose
 
Jing Zhao
No Relationships to Disclose
 
Guanghui Gao
No Relationships to Disclose
 
Jun Zhu
No Relationships to Disclose
 
Sha Zhao
No Relationships to Disclose
 
ChunXia Su
No Relationships to Disclose